Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 12Terminated 3Unknown 2Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Plasma cell 1Other neoplasm 1Dermatologic 1

Conditions

Leukemia 15Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Lymphoma, Non-Hodgkin 8Lymphoma 8Leukemia, Myeloid, Acute 8Multiple Myeloma 6Myelodysplastic Syndromes 5Lymphoma, Large B-Cell, Diffuse 5Leukemia, Myeloid, Chronic-Phase 5Neuroblastoma 4Hodgkin Disease 4Graft vs Host Disease 4Congenital Abnormalities 4Recurrence 3Neoplasms, Plasma Cell 3Lymphoma, Mantle-Cell 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Follicular 3Leukemia, Myelomonocytic, Juvenile 3Leukemia, Lymphocytic, Chronic, B-Cell 3Burkitt Lymphoma 3Sarcoma 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Neuroectodermal Tumors, Primitive, Peripheral 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, Extranodal NK-T-Cell 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Myelomonocytic, Acute 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Leukemia, Myeloid, Accelerated Phase 2

Interventions

Cyclophosphamide 5Vincristine 4Doxorubicin 3fludarabine phosphate 2Psychiatric Rehabilitation 2Prednisone 2Prednisolone 2Peripheral Blood Stem Cell Transplantation 2Mycophenolic Acid 2Melphalan 2Flow Cytometry 2Etoposide 2Cytarabine 2Cyclosporine 2Busulfan 2Antilymphocyte Serum 2Alemtuzumab 2sargramostim 1ruxolitinib 1nelarabine 1motesanib diphosphate 1carbendazim 1Transplantation 1Therapeutics 1Steroids 1Sensitivity and Specificity 1S-1,2-dichlorovinyl-N-acetylcysteine 1Ritonavir 1Radiotherapy 1Polymerase Chain Reaction 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Precursor T-Cell Lymphoblastic Leukemia-Lymphoma × Busulfan × Clear all
NCT05598593 2022-10-28

Modified TBF Regimen as Conditioning Regimen Prior to Allo-HSCT for T-ALL/LBL

First Affiliated Hospital of Zhejiang University

Phase 2 Unknown
70 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT00740467 2010-01-28

Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disorders

National Cancer Institute (NCI)

Phase 2 Unknown
50 enrolled
DermatologicLymphoidOther hematologic neoplasmOther neoplasmPlasma cell

Congenital Abnormalities, Burkitt Lymphoma, Graft vs Host Disease, Hodgkin Disease, Immunoblastic Lymphadenopathy, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Precancerous Conditions, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡